About 60% of cancers are preventable

Health Care, Heart Care Foundation of India Comments Off

Awareness generation and switching to a healthier lifestyle are key

New Delhi, 31 January 2018: A recent report indicates that the BRICS grouping of countries — Brazil, Russia, India, China and South Africa — are losing billions of dollars in productivity owing to cancer. India recorded a total productivity loss of $6.7 billion because of cancer, representing 0.36% of our GDP. The costs and logistical difficulties in implementing screening and treatment programmes in the BRICS countries underscore the importance of cancer prevention.

About 40% of cancers in the country (such as lung cancer and cancers of mouth) are caused by tobacco use and another 20% from infections such as hepatitis B that cause liver cancer and human papillomavirus, which can lead to cervical cancer. Cancer cases in India are rising not just because of better diagnostic facilities but also owing to the shift in the way we lead our lives.

Speaking about this, Padma Shri Awardee Dr K K Aggarwal, President Heart Care Foundation of India (HCFI) and Immediate Past National President Indian Medical Association (IMA), said, “The burden of cancer cases in India is rising. About one million new cases of cancer occur in India every year. The most common cancer among women is breast cancer, while mouth cancer is the commonest cancer among men. About one-third of cancer deaths are related to 5 leading behavioral and dietary risks namely tobacco, high BMI, low fruit and vegetable consumption, lack of physical activity, and alcohol use. Creating awareness becomes especially important as only 12.5 per cent of patients come for treatment in early stages of the disease.”

Cancer is a class of diseases characterized by out-of-control cell growth. There are over 100 different types of cancer, and each is classified by the type of cell that is initially affected. Carcinogens are a class of substances that are directly responsible for damaging DNA, promoting or aiding cancer.

Adding further, Dr Aggarwal, who is also Group Editor of IJCP, said, “We all know that cancer, if detected early, can be treated at a much lower cost compared to that incurred when diagnosed at an advanced stage. Its mortality rate is also lowered substantially if people report for screening when the earliest symptoms manifest. Unfortunately, nearly two-thirds of cancer cases are diagnosed at an advanced stage, reducing patients’ chances of cure and survival.”

Here are some lifestyle changes one can make to prevent cancer.

Avoid using tobacco in any form: Smoking has been linked to various types of cancer — including cancer of the lung, mouth, throat, larynx, pancreas, bladder, cervix and kidney. Chewing tobacco has been linked to cancer of the oral cavity and pancreas.

Consume a healthy diet: A diet rich in fruits, vegetables, and whole grains is important to prevent the risk of cancer.

Maintain a healthy weight: This can lower the risk of various types of cancer, including cancer of the breast, prostate, lung, colon and kidney. Physical activity every day is important to not just reduce weight but also keep fit.

Avoid risky behaviors: Habits such as unsafe sex and sharing needles can lead to infections that, in turn, might increase the risk of cancer.

Its time to revise the ceiling price of coronary stents

Health Care Comments Off

The National Pharmaceutical Pricing Authority (NPPA) fixed the ceiling prices of coronary stents vide a notification dated February 13, 2017, which was valid for one year. This decision is to be revisited now in February 2018.

As per an order dated January 29, NPPA in its meeting to be held on February 5, 2018 in the Conference Room of NPPA will hear all the stakeholders.

On January 30, the NPPA will have met eminent Intervention Cardiologists and on February 5, a meeting is scheduled with AdvaMed, MTal, AIMED, ISMA, AMCCI, AMCHAM. ASSOCHAM, CM, FICCI, PHDCC&I, Multinational stent manufacturing companies, Indian Stent manufacturing companies and ADEH, AIDAN. CAI, ORF, Oxfam India. PHFI.

Apart from the above-mentioned stakeholders, if any formal stakeholder has been left out and wants to put forward its views, they are requested to send an email in this regard to chairman.nppa@nic.in for getting confirmation for the meeting. Only one representative of a stent manufacturing company may be allowed.

In a memorandum dated November 9, 2017, the NPPA asked domestic and foreign stent makers to submit their representations on stent pricing by December 31.  In the same month Abbott Laboratories refused to introduce their latest stent Xience Sierra in India. Earlier in September, it had received permission to withdraw its premium Xience Alpine metallic stents as well as its dissolving stents.

The stent price cap was also discussed at the October 26 US India Trade Policy Forum in Washington DC.

In September, US trade representative wrote to Indian commerce minister and the prime minister’s principal secretary that the policy had created serious problems for US stent makers in India. He also urged India not to extend caps to other devices. The matter was also discussed during Prime Minister Narendra Modi’s visit to Washington in June last year.

Will NPPA succumb to pressure from the imported device industry. Will the Prime Minister’s ‘Make in India’ policy suffer?

Let’s wait… the NPPA stakeholder consultation will decide the fate of ceiling price of stents and whether it will allow new stents in the future at a higher cost.

Dr KK Aggarwal

Padma Shri Awardee Vice President CMAAO Group Editor-in-chief IJCP Publications

President Heart Care Foundation of India

Immediate Past National President IMA